The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ligand Pharmaceuticals Incorporated(NASDAQ:LGND) 
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; ...
Ligand Pharmaceuticals Days Payable Outstanding ttm (DPO)
Ligand Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Ligand Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Ligand Pharmaceuticals Op Cashflow Per Share ttm
Ligand Pharmaceuticals Free Cashflow Per Share ttm
Ligand Pharmaceuticals Cash Per Share ttm
Ligand Pharmaceuticals P/S ratio ttm
Ligand Pharmaceuticals (GAAP) P/E ratio ttm
Ligand Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.